… Factor V Leiden is a common thrombophilic mutation. METHODS: The prospective outcome
of untreated pregnancies amongst 25 women heterozygous for the Factor V Leiden allele …

… untreated pregnancies among women with recurrent miscarriage (RM) at <12 weeks’ gestation
who were heterozygous for factor V Leiden … pregnancies in carriers of factor V Leiden (12/…

The conclusions of studies to date which evaluate a possible association between factor V
Leiden and adverse pregnancy outcome have been conflicting. This study was undertaken to …

… pregnancy and the postpartum period. VTE occurs in approximately 1 in 1500 pregnancies,
and up to one fourth of untreated … of VTE in a previous pregnancy have a higher prevalence …

… Factor V gene (the Leiden mutation), represents the most common genetic cause of thrombophilia.
The Leiden mutation has been significantly related to pregnancy … during pregnancy (8-…

… in individuals with and without the factor Leiden mutation. … of unselected pregnant women
screened for Factor V Leiden both … trials including an untreated control group confirming the …

… pregnancies in 95 women who were factor V Leiden homozygous, 425 in 195 women who
were factor V Leiden … % birth rate without treatment. Moreover, the prevalence of homozygous …

… V Leiden and recurrent pregnancy loss in comparison to historical, untreated pregnancies …
This type of study has many limitations such as the absence of an untreated control group, the …

… Pregnancy is regarded as a physiologically acquired … system change during normal
gestation. The association of … with various pregnancy complications: early pregnancy loss, late …

… Therefore, it could be argued that the successes in this study might well have occurred
without treatment. Our purpose in this preliminary extended case report presentation was to …